Ampicillin gentamicin clindamycin
PreclinicalSmall molecule
Ampicillin gentamicin clindamycin is one of 9 small molecule programs targeting Chorioamnionitis. It is currently in Preclinical.
1
Indications
1
Total Trials
0
Active Trials
8
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
11 competitors in Chorioamnionitis
#DrugCompanyPhaseTrials
1Garamycin
SSchering-Plough
Approved
Viramune
Boehringer IngelheimPhase 3
Flagyl
DDePuy Orthopaedics
Phase 3
E-Mycin
AAzurity Pharmaceuticals
Phase 3
Cysteine Hydrochloride
NovartisPhase 2
Unasyn
SStanford University
Phase 3
Ampicillin Sodium
UUniversity of Southern California
Phase 3
Ampicillin/gentamicin
SStanford University
Phase 3
Ampicillin gentamicin clindamycin
UUnited States Naval Medical Center, Portsmouth
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]
- [4]
Details